This inventor holds 3 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004-2006.
Location History:
- Albany, GA (US) (2004)
- Springfield, VA (US) (2004 - 2006)
Company Filing History:
Years Active: 2004-2006
Title: Kim Deal: Innovator in Radioisotope Chelation Complexes
Introduction
Kim Deal is a prominent inventor based in Springfield, VA (US). She has made significant contributions to the field of radioisotope chelation complexes, with a focus on innovative methods of synthesis and application. With a total of 3 patents, her work has the potential to impact medical treatments and diagnostics.
Latest Patents
Kim Deal's latest patents include groundbreaking inventions such as Ac-HEHA and related compounds, methods of synthesis, and methods of use. The present invention provides an α-particle-emitting radioisotope chelation complex comprising Actinium (Ac) and 1,4,7,10,13,16-hexaazacyclohexadecane-N,N',N'',N'',N'',N''-hexaacetic acid (HEHA) (Ac-HEHA). This invention also includes a bifunctional HEHA and a bifunctional Ac-HEHA, which can be conjugated to a targeting agent. Furthermore, the invention outlines methods for treating diseases, including cancer, and methods for decontaminating individuals exposed to Ac.
Another notable patent involves transition metal complexes of N,N',N''-trialkyl-cis-1,3,5-triaminocyclohexane. This invention provides related compositions and methods of synthesis and use, both in vitro and in vivo, serving as therapeutic agents or delivery/imaging agents.
Career Highlights
Kim Deal is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to explore innovative solutions in the field of medical science.
Collaborations
Throughout her career, Kim has collaborated with notable colleagues, including Martin Wade Brechbiel and Roy P Planalp. These partnerships have further enhanced her research and development efforts.
Conclusion
Kim Deal is a trailblazer in the field of radioisotope chelation complexes, with a focus on innovative methods that hold promise for medical applications. Her contributions continue to shape the landscape of medical research and treatment options.